Sophia Khan, MD
Rheumatology · Fishkill, NYNPI 1750641601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $679, 2.1 times the $328 reported in 2022. That places this record below the midpoint for rheumatology clinicians in NY, where the typical reported total is $1,764.
Across 61 payments — averaging $28.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$310
- Amgen$242
- AbbVie$233
- Novartis$172
- Johnson & Johnson$132
- Ascendis Pharma Endocrinology Inc$114
- plus $551 from 15 others
What the payments were for
- Food & beverage$1,753100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 3 | $310 |
| Amgen | 10 | $242 |
| AbbVie | 7 | $233 |
| Novartis | 8 | $172 |
| Johnson & Johnson | 5 | $132 |
| Ascendis Pharma Endocrinology Inc | 4 | $114 |
| Abbott | 4 | $82 |
| Bayer | 3 | $70 |
| Amneal Pharmaceuticals LLC | 2 | $58 |
| GSK | 3 | $56 |
| Lilly USA, LLC | 2 | $52 |
| Medtronic | 1 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $32 |
| UCB, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$100
How this compares
$1,753 in reported general payments places this provider in the 45th percentile of 541 rheumatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 143 | $6,367 |
| Risedronate Sodium DrRisedronate Sodium | 14 | $4,462 |
| Leflunomide | 39 | $4,355 |
| Risedronate Sodium | 21 | $1,976 |
| MethotrexateMethotrexate Sodium | 73 | $1,751 |
| Sulfasalazine DrSulfasalazine | 27 | $1,242 |
| Prednisone | 119 | $1,070 |
| Sulfasalazine | 12 | $620 |
| Pantoprazole Sodium | 29 | $329 |
| Gabapentin | 24 | $322 |
| Alendronate Sodium | 16 | $253 |
| Allopurinol | 15 | $221 |
| Celecoxib | 12 | $163 |
| Meloxicam | 17 | $11 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Fishkill
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Kostas BotsoglouCheektowaga$2.6M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Richard FurieNew Hyde Park$746K
- Barry GruberBabylon$742K
- Olga PetrynaNew York$509K
- Sanjay GodhwaniWading River$472K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.